doi: 10.6026/97320630018170.
eCollection 2022.
Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
Affiliations
- PMID: 36518123
- PMCID: PMC9722428
- DOI: 10.6026/97320630018170
Item in Clipboard
Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
Bioinformation.
.
Abstract
It is of interest to document the Molecular Dynamics Simulation and docking analysis of NF-κB target with sulindac sodium in combating COVID-19 for further consideration. Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) of the arylalkanoic acid class that is marketed by Merck under the brand name Clinoril. We show the binding features of sulindac sodium with NF-κB that can be useful in drug repurposing in COVID-19 therapy.
Keywords: COVID-19; NF-κB; SARS-CoV2; molecular dynamics simulation; sulindac sodium.
© 2022 Biomedical Informatics.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Similar articles
-
Sulindac activates NF-κB signaling in colon cancer cells.Cell Commun Signal. 2013 Oct 1;11:73. doi: 10.1186/1478-811X-11-73. Cell Commun Signal. 2013. PMID: 24083678 Free PMC article.
-
The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB.Oncogene. 2008 Apr 17;27(18):2648-55. doi: 10.1038/sj.onc.1210891. Epub 2007 Dec 3. Oncogene. 2008. PMID: 18059344
-
Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.Ann N Y Acad Sci. 2003 Dec;1010:273-7. doi: 10.1196/annals.1299.047. Ann N Y Acad Sci. 2003. PMID: 15033733
-
Effects of nonsteroidal anti-inflammatory drugs in healthy subjects.Am J Med. 1986 Aug 25;81(2B):58-70. doi: 10.1016/0002-9343(86)90908-3. Am J Med. 1986. PMID: 3092666 Review.
-
Clinical pharmacokinetics of sulindac. A dynamic old drug.Clin Pharmacokinet. 1997 Jun;32(6):437-59. doi: 10.2165/00003088-199732060-00002. Clin Pharmacokinet. 1997. PMID: 9195115 Review.
Cited by
-
Ras-related associated with diabetes genes for biomarker-based therapeutics in cancer: A comparative evolutionary genomic study.Saudi Med J. 2024 Feb;45(2):111-120. doi: 10.15537/smj.2024.45.2.20230564. Saudi Med J. 2024. PMID: 38309727 Free PMC article.
-
Integrative Investigation of Flavonoids Targeting YBX1 Protein-Protein Interaction Network in Breast Cancer: From Computational Analysis to Experimental Validation.Mol Biotechnol. 2024 Nov 20. doi: 10.1007/s12033-024-01311-6. Online ahead of print. Mol Biotechnol. 2024. PMID: 39565541
-
Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.PLoS One. 2023 Dec 15;18(12):e0295714. doi: 10.1371/journal.pone.0295714. eCollection 2023. PLoS One. 2023. PMID: 38100507 Free PMC article.
-
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.Med Oncol. 2024 Mar 28;41(5):101. doi: 10.1007/s12032-024-02342-4. Med Oncol. 2024. PMID: 38546811
-
Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.Int J Mol Sci. 2024 Jan 2;25(1):592. doi: 10.3390/ijms25010592. Int J Mol Sci. 2024. PMID: 38203761 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous